BRIEF published on 05/12/2026 at 10:10, 3 months 21 days ago Scantox Launches Cloud-Based Mutagenesis App for DuplexSeq™ Bioinformatics Cloud-based Mutagenesis Scantox DuplexSeq™
BRIEF published on 05/12/2026 at 10:10, 3 months 21 days ago Scantox lance une application de mutagénèse basée sur le cloud pour DuplexSeq™ Bioinformatique Basé Sur Le Cloud Mutagenèse Scantox DuplexSeq™
PRESS RELEASE published on 05/12/2026 at 10:05, 3 months 21 days ago Scantox Upgrades DuplexSeq™ Bioinformatics with Cloud-Based Mutagenesis App Scantox upgrades DuplexSeq™ bioinformatics with cloud-based Mutagenesis App, offering error-corrected sequencing on a scalable platform Bioinformatics Cloud-based DuplexSeq Mutagenesis Scantox
BRIEF published on 03/31/2026 at 10:10, 5 months 2 days ago Gentronix Joins Scantox Brand Amid Expansion Efforts Mergers & Acquisitions Industry Integration Scantox Group Genomic Safety Genetic Toxicology
BRIEF published on 03/31/2026 at 10:10, 5 months 2 days ago Gentronix rejoint la marque Scantox dans le cadre de ses efforts d'expansion Fusions Et Acquisitions Intégration Industrielle Groupe Scantox Sécurité Génomique Toxicologie Génétique
PRESS RELEASE published on 03/31/2026 at 10:05, 5 months 2 days ago Gentronix Now Operating Under the Scantox Brand Scantox Group announces Gentronix now operates under the Scantox brand as Scantox Manchester, offering integrated genetic toxicology and genomic safety services Acquisition Scantox Group Genomic Safety Genetic Toxicology Gentronix
BRIEF published on 02/26/2026 at 10:15, 6 months 4 days ago Scantox Group Acquires DuplexSeq™ Genomics Safety Business Scantox Group DuplexSeq Genomic Safety Mutagenesis TwinStrand Biosciences
BRIEF published on 02/26/2026 at 10:15, 6 months 4 days ago Le groupe Scantox acquiert l'activité de sécurité génomique DuplexSeq™ DuplexSeq TwinStrand Biosciences Groupe Scantox Sécurité Génomique Mutagenèse
PRESS RELEASE published on 02/26/2026 at 10:10, 6 months 4 days ago Scantox Acquires DuplexSeq™ Nonclinical Genomics Safety Business from TwinStrand Biosciences Scantox Group acquires DuplexSeq™ Nonclinical Genomics Safety Business from TwinStrand Biosciences, enhancing mutagenesis testing services globally Acquisition Scantox Group DuplexSeq Genomics Safety Mutagenesis Testing
Published on 09/02/2026 at 14:30, 6 minutes ago Solitario Completes Phase-One Drilling at Golden Crest - Reports Initial Drill Results for Ponderosa
Published on 09/02/2026 at 14:00, 36 minutes ago Orogen Royalties Acquires Two Gold Projects in Southwest Utah
Published on 09/02/2026 at 14:00, 36 minutes ago Datametrex Plans to Focus on AI, Data Centre, and Patent Licensing
Published on 09/02/2026 at 13:00, 1 hour 36 minutes ago Snipp-Powered Loyalty Programs Earn Two Gold Awards at Loyalty360 Awards
Published on 09/02/2026 at 13:00, 1 hour 36 minutes ago Eagle Plains and Earthwise Intersect Gold Mineralization in all Holes at the Iron Range Precious Metals Project, SE BC
Published on 09/02/2026 at 13:00, 1 hour 36 minutes ago Nebius to participate in upcoming investor conferences
Published on 09/02/2026 at 12:30, 2 hours 6 minutes ago Immunic to Host Virtual Relapsing Multiple Sclerosis R&D Day on September 9, 2026
Published on 09/02/2026 at 11:42, 2 hours 54 minutes ago Prof. Dr. Michael A. Rübhausen Joins the Medical Advisory Board of Viromed Medical AG
Published on 09/02/2026 at 11:30, 3 hours 6 minutes ago Tolochenaz accueille un nouveau carport photovoltaïque d'envergure réalisé par Romande Energie
Published on 09/02/2026 at 11:09, 3 hours 27 minutes ago Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
Published on 09/02/2026 at 07:43, 6 hours 52 minutes ago Accor launches an offering of bonds convertible into new shares and/or exchangeable for existing shares (OCEANEs) due 2032 for a nominal amount of €380 million and a concurrent partial repurchase offer with respect to its outstanding OCEANEs due 2027 by
Published on 09/02/2026 at 07:43, 6 hours 52 minutes ago Accor lance une émission d’obligations à option de conversion en actions nouvelles et/ou d’échange en actions existantes (OCEANEs) à échéance 2032 pour un montant nominal de 380 millions d’euros et une offre concomitante de rachat partiel de s
Published on 09/01/2026 at 19:00, 19 hours 36 minutes ago Covivio - Information on total number of voting rights and share capital
Published on 09/01/2026 at 19:00, 19 hours 36 minutes ago Covivio - Informations relatives au nombre total de droits de vote et d’actions composant le capital social
